The Richmond, California-based company will join several biotech firms listing their shares this year. The trend comes as anti-obesity drug developers have attracted Wall Street interest and secured the support of several venture capital heavyweights.
Tag Archive for: azelaprag
The company’s experimental drug, azelaprag, is being developed for the treatment of obesity.